Evidence map›Paper›PMID 25066696›Full record

ArticleJournal of molecular and cellular cardiology2014

Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity.

Dunja Aksentijević, Debra J McAndrew, Anja Karlstädt, Sevasti Zervou, Liam Sebag-Montefiore, Rebecca Cross, Gillian Douglas, Vera Regitz-Zagrosek, Gary D Lopaschuk, Stefan Neubauer and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Bat power-metabolic profiling of the Egyptian fruit batbioRxiv : the preprint server for biology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Dunja AksentijevićDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, UK; British Heart Foundation Centre for Research Excellence, University of Oxford, UK.
Debra J McAndrewDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, UK; British Heart Foundation Centre for Research Excellence, University of Oxford, UK.
Anja KarlstädtInstitute of Gender in Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany; Center for Cardiovascular Research, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Sevasti ZervouDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, UK; British Heart Foundation Centre for Research Excellence, University of Oxford, UK.
Liam Sebag-MontefioreDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, UK; British Heart Foundation Centre for Research Excellence, University of Oxford, UK.
Rebecca CrossDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, UK; British Heart Foundation Centre for Research Excellence, University of Oxford, UK.
Gillian DouglasDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, UK; British Heart Foundation Centre for Research Excellence, University of Oxford, UK.
Vera Regitz-ZagrosekInstitute of Gender in Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany; Center for Cardiovascular Research, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Gary D LopaschukMazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
Stefan NeubauerDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, UK; British Heart Foundation Centre for Research Excellence, University of Oxford, UK.
Craig A LygateDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, UK; British Heart Foundation Centre for Research Excellence, University of Oxford, UK. Electronic address: clygate@well.ox.ac.uk.
British Heart Foundation · GBBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEUniversity of Alberta · CA

Funding

British Heart Foundation PG/05/141/20098British Heart Foundation PG/08/080/25726British Heart Foundation RG/07/003/23133British Heart Foundation RG/13/8/30266Wellcome TrustWellcome Trust 90532/Z/09/Z
6 · The paper itself

Abstract

unlabelledInhibition of malonyl-coenzyme A decarboxylase (MCD) shifts metabolism from fatty acid towards glucose oxidation, which has therapeutic potential for obesity and myocardial ischemic injury. However, ~40% of patients with MCD deficiency are diagnosed with cardiomyopathy during infancy.

aimTo clarify the link between MCD deficiency and cardiac dysfunction in early life and to determine the contributing systemic and cardiac metabolic perturbations. METHODS AND

resultsMCD knockout mice ((-/-)) exhibited non-Mendelian genotype ratios (31% fewer MCD(-/-)) with deaths clustered around weaning. Immediately prior to weaning (18days) MCD(-/-) mice had lower body weights, elevated body fat, hepatic steatosis and glycogen depletion compared to wild-type littermates. MCD(-/-) plasma was hyperketonemic, hyperlipidemic, had 60% lower lactate levels and markers of cellular damage were elevated. MCD(-/-) hearts exhibited hypertrophy, impaired ejection fraction and were energetically compromised (32% lower total adenine nucleotide pool). However differences between WT and MCD(-/-) converged with age, suggesting that, in surviving MCD(-/-) mice, early cardiac dysfunction resolves over time. These observations were corroborated by in silico modelling of cardiomyocyte metabolism, which indicated improvement of the MCD(-/-) metabolic phenotype and improved cardiac efficiency when switched from a high-fat diet (representative of suckling) to a standard post-weaning diet, independent of any developmental changes.

conclusionsMCD(-/-) mice consistently exhibited cardiac dysfunction and severe metabolic perturbations while on a high-fat, low carbohydrate diet of maternal milk and these gradually resolved post-weaning. This suggests that dysfunction is a common feature of MCD deficiency during early development, but that severity is dependent on composition of dietary substrates.

Indexed as

WeaningAgingAnimalsCarboxy-LyasesComputer SimulationDiet, High-FatFemaleGene DeletionGenotypeHeartMaleMice, Inbred C57BLMice, KnockoutMyocardiumPhenotypeSubstrate SpecificityCarboxy-Lyasesmalonyl-CoA decarboxylaseCardiac dysfunctionFatty acidsHeart failureMetabolism

Identifiers

PMID25066696
PMCPMC4169183
OpenAlexW2084343608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.